PharmEasy Receives CCI Nod To Raise Funds From Canadian Pension Board

PharmEasy Receives CCI Nod To Raise Funds From Canadian Pension Board

SUMMARY

Besides CDPQ, US-based TPG has sought CCI’s approval to acquire a 7% stake in PharmEasy

The CDPQ had previously participated in PharmEasy’s $220 Mn round in 2019

It has raised $328 Mn across seven funding rounds from investors till date and had merged with Medlife last year

Mumbai-based online pharmacy PharmEasy has received the Competition Commission of India’s approval for investment from Canada-based CDPQ (Caisse de dépôt et placement du Québec) in exchange for a 2% stake in the parent company API Holdings. The Canadian pension fund CDPQ had previously participated in PharmEasy’s $220 Mn round in 2019.

Both the companies have not disclosed any other transaction details of this latest round. But CDPQ isn’t the only one running after stake in the epharmacy startup. US-based private equity firm TPG sought CCI’s approval to acquire a 7% stake in PharmEasy, which intends to use this capital to deepen its distribution network and build a technology-first product. The approval was filed in December, two months after PharmEasy got the green light to sign a merger with rival Medlife.

Under the merger, API Holdings acquired 100% equity shares in Medlife, whereas Medlife’s promoters got a 19.95% stake in the combined entity. Media reports had suggested that the combined entity will be valued at $1.2 Bn, but that does not seem to be the case here. An Entrackr report citing sources added that PharmEasy did not surpass the unicorn valuation after this investment by CDPQ.

The healthtech startup was founded by Dharmil Sheth and Dr. Dhaval Shah in 2015. The company caters to the chronic care segment and offers a range of services such as teleconsultation, medicine deliveries, and sample collections for diagnostic tests. It has marked its presence in more than 1000 cities, and also offers a subscription-based service.

It has raised $328 Mn across seven funding rounds from investors like Temasek, Bessemer Venture Partners, and Infosys’ Nandan Nilekani, among others. The company last raised $100 Mn from Singapore-based Temasek in August 2019 at a valuation of $650 Mn-$700 Mn.

The epharmacy segment has toughened up during the pandemic, with the entry of several big businesses such as Amazon and Reliance. While Amazon launched its own epharmacy verticle, Reliance acquired Netmeds in a $83 Mn deal. Now Tata Group has planned out an entry as well by acquiring a majority stake in 1mg for $250 Mn. It is important to note that 1mg has the biggest market share in the online medicine domain among all the other startups operating here.

You have reached your limit of free stories
Become An Inc42 Plus Member

Become a Startup Insider in 2024 with Inc42 Plus. Join our exclusive community of 10,000+ founders, investors & operators and stay ahead in India’s startup & business economy.

2 YEAR PLAN
₹19999
₹7999
₹333/Month
Unlock 60% OFF
Cancel Anytime
1 YEAR PLAN
₹9999
₹4999
₹416/Month
Unlock 50% OFF
Cancel Anytime
Already A Member?
Discover Startups & Business Models

Unleash your potential by exploring unlimited articles, trackers, and playbooks. Identify the hottest startup deals, supercharge your innovation projects, and stay updated with expert curation.

PharmEasy Receives CCI Nod To Raise Funds From Canadian Pension Board-Inc42 Media
How-To’s on Starting & Scaling Up

Empower yourself with comprehensive playbooks, expert analysis, and invaluable insights. Learn to validate ideas, acquire customers, secure funding, and navigate the journey to startup success.

PharmEasy Receives CCI Nod To Raise Funds From Canadian Pension Board-Inc42 Media
Identify Trends & New Markets

Access 75+ in-depth reports on frontier industries. Gain exclusive market intelligence, understand market landscapes, and decode emerging trends to make informed decisions.

PharmEasy Receives CCI Nod To Raise Funds From Canadian Pension Board-Inc42 Media
Track & Decode the Investment Landscape

Stay ahead with startup and funding trackers. Analyse investment strategies, profile successful investors, and keep track of upcoming funds, accelerators, and more.

PharmEasy Receives CCI Nod To Raise Funds From Canadian Pension Board-Inc42 Media
PharmEasy Receives CCI Nod To Raise Funds From Canadian Pension Board-Inc42 Media
You’re in Good company